Faces political, industry, or legal opposition
Affected groups may oppose the path, and it may invite legal disputes over authority or obligations. This matters when opposition blocks or weakens the policy, and less when there is durable agreement.
Under your mix of paths
Caused or worsened by these paths
A cost these paths share. Each path's page says how it applies there.
Tax financing is politically harder to increase than premiums.
Setting a public fee schedule creates a target for lobbying.
The rate commission becomes a target for lobbying.
Large systems retain political influence over the rate commission.
Government licensing of drug patents can lead to trade disputes with partners.
Shorter medical programs beginning after high school require changes to accreditation.
Insurers may resist requirements to give up their own forms, codes, and rules.
Some clinicians are reluctant to prescribe medication for addiction despite broader prescribing access.
Supervised consumption sites and other harm reduction services face community opposition and legal uncertainty.
A ban on private insurance for publicly covered services can face legal challenges, as in Canada.
Once new drugs or devices receive immediate coverage, withdrawing that coverage later is difficult.
Conditioning favorable pricing on prompt launches can face legal challenges.
Immediate coverage for all residents raises political concerns.